Seoul, South Korea

Hyun-Jun Youn

This inventor holds 1 USPTO granted patent. Top assignee: Snu Rdb Foundation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun-Jun Youn. Retrieved from https://idiyas.com/inventor/hyun-jun-youn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hyun-Jun Youn

Introduction

Hyun-Jun Youn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immune adjuvants. His work focuses on enhancing therapeutic options for autoimmune diseases.

Latest Patents

Hyun-Jun Youn holds a patent for novel α-galactosylceramide derivatives, which include pharmaceutically acceptable salts and preparation methods. The patent also covers pharmaceutical compositions that utilize these derivatives as active ingredients. These innovative compounds are designed to direct cytokine secretion toward IL-4, offering potential therapeutic benefits for conditions such as type 1 diabetes and multiple sclerosis.

Career Highlights

Youn's career is marked by his dedication to advancing medical science through innovative research. His work has led to the development of new therapeutic strategies that could significantly impact the treatment of autoimmune diseases. He is associated with the Snur & Db Foundation, where he continues to explore the potential of his inventions.

Collaborations

Hyun-Jun Youn collaborates with esteemed colleagues, including Chang-Yuil Kang and Sanghee Kim. Their combined expertise fosters a productive research environment that enhances the development of groundbreaking medical solutions.

Conclusion

Hyun-Jun Youn's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing complex medical challenges. His work on α-galactosylceramide derivatives represents a promising advancement in the treatment of autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…